{"id":"audit-2026-02-19-expansion","date":"2026-02-19","type":"corpus_audit","description":"Full 8-pass audit after coverage expansion (93 â†’ 128 conditions)","commit":"788e8cb","file_count":128,"schema_version":"2.0","results":{"cross_file_dosing":23,"unit_normalization":0,"dose_range_anomaly":0,"citation_validation":0,"duplicate_detection":5,"high_risk_med_tagging":114,"icd10_validation":0,"guideline_currency":1},"total_findings":143,"critical_findings":0,"conditions_added":["neuroleptic-malignant-syndrome","serotonin-syndrome","acute-agitation","rhabdomyolysis","spontaneous-pneumothorax","guillain-barre-syndrome","subdural-hematoma","pelvic-fracture","penetrating-chest-trauma","spinal-cord-injury","septic-arthritis","fourniers-gangrene","svt","pericarditis-myocarditis","infective-endocarditis","tetanus","hip-fracture","bronchiolitis","non-accidental-trauma","pyloric-stenosis","acute-gout","complicated-uti","deep-vein-thrombosis","acute-low-back-pain-red-flags","allergic-reaction","hhs","carbon-monoxide-poisoning","electrical-injury","retinal-detachment","acute-vertigo","lithium-toxicity","acute-cholecystitis","herpes-zoster-ophthalmicus","threatened-abortion","mastoiditis"],"notes":"All 35 new conditions compiled with 5+ PMID-verified sources, cross-file drug consistency verified, all 7 required sections present. ESI distribution rebalanced: ESI-1 37%, ESI-2 45%, ESI-3 17%."}
